Glycans: forgotten villain in the battle against viruses
With the dawn of Covid-19 and the ever-present threat of continual viral evolution, an increased focus on viral structure in order to produce vaccines has never been more apparent. The phrase ‘spike protein’ has been integrated into everyday language, yet the role of glycans in viruses has been less mentioned. This begs the questions: what are glycans, why has their role in viruses been overlooked, and how important are they?
Generally, ‘glycans’ is an alternate name for polysaccharides. They are comprised of chains of monosaccharides, such as the singular sugar units glucose and fructose, which have been glycosidically linked together. This involves the covalent bonding of hemiacetal groups on a saccharide unit with a hydroxyl group of a neighbouring unit.
There are two discernible categories of glycans: N- and O-linked glycans. In eukaryotes (all animals, plants, and fungi), N-linked glycans are bonded to the nitrogen of the Asparagine (Asn) residue in the endoplasmic reticulum within cells, whereas O-linked glycans are assembled sequentially by one monosaccharide at a time from a threonine (Thr) or serine (Ser) residue of a peptide.
Glycans form important components of the surface of the virus to enable virus-host interactions, thereby resulting in infection. This occurs through binding of the glycans to cell-surface receptors of the host cell, allowing mutual recognition between the two participants and thus membrane fusion. The virus can subsequently ‘unload’ into the host cell for replication. Using host-cell machinery, the viral N- and O-glycans are then translated and replicated for further infection.
Glycosylation on the surface of the virus has implications on the transmissibility of the virus
Evidently essential for maintaining the cycle of replication of the virus, glycans also play an important role in ensuring virus transmission. Glycosylation patterns within the glycans on the surface of specific viruses invoke varying degrees of infectivity and transmissibility of the virus. It has been found that Covid-19’s infectibility in humans could be accounted for due to the high degree of glycosylation of the ‘spike’ protein. This was determined through the mutation of glycosylation patterns at the N331 and N343 residues of the ‘spike’ protein, which resulted in decreased severity of infection by Covid-19. Thus, it can be ascertained that glycosylation on the surface of the virus has implications on the transmissibility of the virus.
Alternatively, it has been seen that increased N-glycosylation of the HA protein of the influenza A virus causes reduced transmissibility of the virus by initiating the production of immune response proteins. Therefore, it can be suggested that both increased and decreased glycosylation of viral surface proteins can cause varying degrees of viral transmissibility, dependent on the virus.
Glycans therefore show promise in enabling the development of vaccines through their utilization as a target for treatments. For example, the reduction of N-glycosylation in SARS-CoV-2 through the removal of the ‘spike’ protein sites N331 and N343 could allow effective and universal vaccinations to be developed.
Despite the seeming enormity of glycans’ roles in viral infectivity, little research has been conducted into their importance prior to this century
Moreover, research into glycan inhibitors as treatments for viruses has shown that lectins and tetherin could reduce the transmissibility and infectivity of HIV. The former have been found to prevent membrane fusion between the virus and host cell through binding specifically to viral glycans. The latter, in contrast, prevent the spreading of virions by holding them on the surface of the host-virus interface. Tetherins on the host cell surface require N-linked glycosylation of their Asn sites in order to retain virions, thereby indicating the necessity for glycans and glycosylation in both the replication and repression of viruses.
Despite the seeming enormity of glycans’ roles in viral infectivity, little research has been conducted into their importance prior to this century. This is likely due to a lack of advanced technology required to study glycovirology in order to analyse the structural components of glycans. Furthermore, biochemists largely focused on proteins in disease as the targets for antibodies, thereby resulting in little effort in the research of glycans. However, recent advancements in virology due to the emergence of Covid-19 has allowed the potential of glycans as targets to be revealed.
Image: Alexey Solodovnikov and Valeria Arkhipova under CC BY-SA 4.0 License

